Evidence map›Paper›PMID 34006992›Full record

ArticleScientific reports2021

Unusual mode of dimerization of retinitis pigmentosa-associated F220C rhodopsin.

George Khelashvili, Anoop Narayana Pillai, Joon Lee, Kalpana Pandey, Alexander M Payne, Zarek Siegel, Michel A Cuendet, Tylor R Lewis, Vadim Y Arshavsky, Johannes Broichhagen and 2 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 3 countries.

George KhelashviliDepartment of Physiology and Biophysics, Weill Cornell Medical College, New York, NY, 10065, USA. gek2009@med.cornell.edu.
Anoop Narayana Pillai *Department of Biochemistry, Weill Cornell Medical College, New York, NY, 10065, USA.
Joon Lee *Department of Biochemistry, Weill Cornell Medical College, New York, NY, 10065, USA.
Kalpana Pandey *Department of Biochemistry, Weill Cornell Medical College, New York, NY, 10065, USA.
Alexander M PayneTri-Institutional PhD Program in Chemical Biology, Weill Cornell Medical College, New York, NY, 10065, USA.
Zarek SiegelNeurosciences Graduate Program, University of California San Diego, La Jolla, CA, 92093, USA.
Michel A CuendetDepartment of Physiology and Biophysics, Weill Cornell Medical College, New York, NY, 10065, USA.
Tylor R LewisDepartment of Ophthalmology, Duke University Medical Center, Durham, NC, 27710, USA.
Vadim Y ArshavskyDepartment of Ophthalmology, Duke University Medical Center, Durham, NC, 27710, USA.
Johannes BroichhagenLeibniz-Forschungsinstitut Für Molekulare Pharmakologie, Robert-Rössle-Str. 10, 13125, Berlin, Germany.
Joshua LevitzDepartment of Biochemistry, Weill Cornell Medical College, New York, NY, 10065, USA. jtl2003@med.cornell.edu.
Anant K MenonDepartment of Biochemistry, Weill Cornell Medical College, New York, NY, 10065, USA. akm2003@med.cornell.edu.
Cornell University · USDuke Medical Center · USDuke University Hospital · USLeibniz-Forschungsinstitut für Molekulare Pharmakologie · DETri-Institutional PhD Program in Chemical Biology · USUniversity of California, San Diego · US

Funding

VISION RESEARCHP30EY005722 · NEI · DUKE UNIVERSITY · PI Vadim Y Arshavsky · 1985 to 2026
$19.3M
Rhodopsin dimerization: mechanistic basis and functional consequencesR01EY027969 · NEI · WEILL MEDICAL COLL OF CORNELL UNIV · PI ARSHAVSKY, VADIM Y, BURNS, MARIE E · 2017 to 2020
$2.2M
Molecular Mechanisms of Synaptic G Protein-Coupled ReceptorsR35GM124731 · NIGMS · WEILL MEDICAL COLL OF CORNELL UNIV · PI LEVITZ, JOSHUA · 2017 to 2021
$2.1M
Pathological and functional consequences of dimerization-deficient rhodopsin mutationsF32EY029929 · NEI · DUKE UNIVERSITY · PI LEWIS, TYLOR ROBERT · 2019 to 2021
$195k
NEI NIH HHS F32 EY029929NEI NIH HHS P30 EY005722NEI NIH HHS R01 EY027969NIH HHS F32 EY029929NIH HHS R01 EY027969NIH HHS R35 GM124731
6 · The paper itself

Abstract

Mutations in the G protein-coupled receptor (GPCR) rhodopsin are a common cause of autosomal dominant retinitis pigmentosa, a blinding disease. Rhodopsin self-associates in the membrane, and the purified monomeric apo-protein opsin dimerizes in vitro as it transitions from detergent micelles to reconstitute into a lipid bilayer. We previously reported that the retinitis pigmentosa-linked F220C opsin mutant fails to dimerize in vitro, reconstituting as a monomer. Using fluorescence-based assays and molecular dynamics simulations we now report that whereas wild-type and F220C opsin display distinct dimerization propensities in vitro as previously shown, they both dimerize in the plasma membrane of HEK293 cells. Unexpectedly, molecular dynamics simulations show that F220C opsin forms an energetically favored dimer in the membrane when compared with the wild-type protein. The conformation of the F220C dimer is unique, with transmembrane helices 5 and 6 splayed apart, promoting widening of the intracellular vestibule of each protomer and influx of water into the protein interior. FRET experiments with SNAP-tagged wild-type and F220C opsin expressed in HEK293 cells are consistent with this conformational difference. We speculate that the unusual mode of dimerization of F220C opsin in the membrane may have physiological consequences.

Indexed as

DimerizationFluorescence Resonance Energy TransferHEK293 CellsHumansMicellesMolecular Dynamics SimulationOpsinsRetinitis PigmentosaRhodopsinMicellesOpsinsRhodopsin

Identifiers

PMID34006992
PMCPMC8131606
OpenAlexW3160513101

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.